Literature DB >> 2027996

Cerebral MR angiography with multiple overlapping thin slab acquisition. Part I. Quantitative analysis of vessel visibility.

D D Blatter1, D L Parker, R O Robison.   

Abstract

Multiple overlapping thin slab acquisition (MOTSA) is a novel time-of-flight magnetic resonance (MR) angiography technique that combines many of the advantages of multiple-section two-dimensional and direct three-dimensional volume methods. To rigorously evaluate the vascular detail that can be obtained with MOTSA MR angiography, the authors have quantified the frequency of visibility of intracranial arterial segments and have correlated their visibility with vessel size as measured at cut-film angiography and with the position and orientation of the arterial segment. Intracranial arterial segments at least 0.9 mm in diameter (the voxel dimension used in the current application) are consistently visualized with the MOTSA technique. The fraction of small vessels visualized is improved when voxel dimensions are reduced. Visibility is noticeably better in the primary images compared with the maximum-intensity-projection (MIP) images. Top-of-slab saturation and resulting decreased vessel intensity occurred infrequently and did not result in marked image degradation in the axial images.

Mesh:

Year:  1991        PMID: 2027996     DOI: 10.1148/radiology.179.3.2027996

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  Basic principles of magnetic resonance angiography.

Authors:  R R Edelman
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Jan-Feb       Impact factor: 2.740

Review 2.  Advances in vascular echoplanar imaging.

Authors:  J F Debatin; D A Leung; S Wildermuth; D Holtz; G C McKinnon
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Sep-Oct       Impact factor: 2.740

3.  Brain arteriovenous malformations: measurement of nidal volume using a combination of static and dynamic magnetic resonance angiography techniques.

Authors:  S Nagaraja; D Capener; S C Coley; K J Lee; I D Wilkinson; A A Kemeny; P D Griffiths
Journal:  Neuroradiology       Date:  2005-04-15       Impact factor: 2.804

4.  Computer-assisted 3D reconstruction of the terminal branches of the cerebral arteries. III. Posterior cerebral artery and circle of Willis.

Authors:  S Gloger; A Gloger; H Vogt; H J Kretschmann
Journal:  Neuroradiology       Date:  1994-05       Impact factor: 2.804

5.  Computer-assisted 3D reconstruction of the terminal branches of the cerebral arteries. I. Anterior cerebral artery.

Authors:  S Gloger; A Gloger; H Vogt; H J Kretschmann
Journal:  Neuroradiology       Date:  1994-04       Impact factor: 2.804

6.  Computer-assisted 3D reconstruction of the terminal branches of the cerebral arteries. II. Middle cerebral artery.

Authors:  S Gloger; A Gloger; H Vogt; H J Kretschmann
Journal:  Neuroradiology       Date:  1994-04       Impact factor: 2.804

7.  Dual-echo arteriovenography imaging with 7T MRI.

Authors:  Kyongtae Ty Bae; Sung-Hong Park; Chan-Hong Moon; Jung-Hwan Kim; Diana Kaya; Tiejun Zhao
Journal:  J Magn Reson Imaging       Date:  2010-01       Impact factor: 4.813

8.  Vascularization of head and neck paragangliomas: comparison of three MR angiographic techniques with digital subtraction angiography.

Authors:  R van den Berg; M N Wasser; A P van Gils; A G van der Mey; J Hermans; M A van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

9.  Magnetic resonance angiography of supratentorial tumours: comparison with selective digital subtraction angiography.

Authors:  G Wilms; H Bosmans; G Marchal; P Demaerel; J Goffin; C Plets; A L Baert
Journal:  Neuroradiology       Date:  1995-01       Impact factor: 2.804

10.  Can 3T MR angiography replace DSA for the identification of arteries feeding intracranial meningiomas?

Authors:  H Uetani; M Akter; T Hirai; Y Shigematsu; M Kitajima; Y Kai; S Yano; H Nakamura; K Makino; M Azuma; R Murakami; Y Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-18       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.